Chairman & CEO. “Faisal has a proven track record in integrating cutting-edge science with practical, evidence-base PHILADELPHIA, October 24, 2024--New data for AREXVY, GSK’s RSV vaccine ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

Estun , established in 1993, is a leading player in China's robotics market. The company produces a wide range of industrial ...

Marketing: Around the world, brands have learnt that revamping their identities without thinking the exercise through can be met with ridicule and derision — often the hard way. On the other hand, ...

The question of the rights and wrongs of playing cricket against the Afghanistan men’s team is never far from the surface.

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

The company noted that the new presentation has the same composition as the reconstituted vaccine. The submission is based on data demonstrating comparability between the two. GSK's shingles ...

GSK plans five new product approvals by 2025, highlights strong specialty growth, and acquires IDRx for $1 billion to expand its oncology portfolio.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...